MOREADITH RANDALL (Chief Scientific Officer) sold 3.23K shares of SERINA THERAPEUTICS, INC. on the open market
Open‑market sale worth $9.6K. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/17/2025ACC: 0001301120-25-000035
Officer· Chief Scientific Officer
Since Feb 2026
-3.23K
Net shares
Net seller
$9.6K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
3.23K acquired · 6.45K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+3.23K
Price / share
$0.06
Trade value
$193.62
% of position
New position
12/16/2025
0.00→3.23K
Common Stock
Direct
Shares
−3.23K
Price / share
$2.96
Trade value
$9.56K
% of position
New position
12/16/2025
3.23K→0.00
Total
Net shares
+0.00
Net value
-$9.37K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/16/2025 | M · Option Exercise | +3.23K | $0.06 | $193.62 | New position | 0.00 | 3.23K |
| Common Stock Direct | 12/16/2025 | S · Sale | −3.23K | $2.96 | $9.56K | New position | 3.23K | 0.00 |
| Total | +0.00 | -$9.37K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
3.23K shares
Shares
−3.23K
Strike price
0.06
Held after
361.96K
Exercisable
—
12/16/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock3.23K shares | 12/16/2025 | M · Option Exercise | −3.23K | 0.06 | — | 361.96K |